MIRA INFORM REPORT

 

 

Report Date :

06.02.2014

 

IDENTIFICATION DETAILS

 

Name :

AMNEAL LIFE SCIENCES PRIVATE LIMITED

 

 

Registered Office :

882/1 – 871, Village Rajoda, Near Hotel Kankavati, Bavla – 382 220, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

31.03.2008

 

 

Com. Reg. No.:

04-053430

 

 

Capital Investment / Paid-up Capital :

Rs.217.068 millions

 

 

CIN No.:

[Company Identification No.]

U73100GJ2008PTC053430

 

 

PAN No.:

[Permanent Account No.]

AAGCA9685C

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing of Pharmaceutical Bulk Drugs.

 

 

No. of Employees :

600 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (27)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 1100000

 

 

Status :

Yet to commence commercial activities.

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

Comments :

Subject is held by Amneal Pharmaceuticals LLC USA and Amneal Pharma Investment Holdings (Amneal Group).

 

Even though the company was incorporated in the year 2008, It is yet commence its commercial activities.

 

However, the capital base of the company appears to be strong. The company get good support from its holding companies. Business is active. Payments are unknown.

 

In view of experienced promoters, the company can be considered for business dealing with some caution.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

The services sector, the largest contributor to India’s GDP, contracted for the sixth consecutive month in December, as orders dipped. However, hiring has risen.  Direct tax collections rose 12.3 % during the April – December period of the current financial year.  The government has decided to retain 100 per cent foreign direct investment in both greenfield (new) and brown field (existing) pharmaceutical companies, despite concerns over genetic drugs going out of production, if multi-national companies take over domestic ones. In M&A deals, a non compete clause would not be allowed, except in special circumstances. The Department of Industrial Policy and Promotion plans to release the next edition of its consolidated foreign direct investment policy document on March 31, incorporating changes made in the past year. DIPP compiles all policies related to India’s FDI regime into a single document to make it easy for investors to understand. 185 million estimated number of mobile internet users in India by June 2014, according to a report by the Internet & Mobile Association of India and IMRB International.  India had 110 million mobile internet users with 25 million in rural areas. $3.77 tn estimated global IT spending in 2014, according to research firm Gartner Inc. The growth forecast for this year is cut to 3.1 %from the earlier estimate of 3.5 %. The spending growth forecast for telecom services – a segment that accounts for more than 40 % at total IT spending – from 1.9 per cent to 1.2 per cent is the main reason for this overall IT cut. A Reserve Bank of India committee has recommended setting up a special category of lenders who would cater to small businesses and households, to expand the number of customers with access to banking services. These banks would focus onproviding payment services and deposit products.  Indian banks want the free use of automated teller machines to be capped at five transactions in a month including that of the bank in which the account is active. This follows state government order to banks to install security guards at ATM booths after a woman banker was assaulted in Bangalore. The government is likely to present a vote on Account in mid-February. The annual Economic Survey will be tabled later in Parliament along with the full Budget. A full Budget for 2014/15 is likely to be present in July by the new government formed after the General Election. The government will soon launch an internet spy system, called Netra, to detect malafide messages. Security agency will deploy the system to capture dubious voice traffic on applications such as Skype and Google Talk, as well as tweeters.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Fund Bases Limit=BB

Rating Explanation

Moderate risk of default.

Date

19.03.2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

INFORMATION PARTED BY

 

Name :

Mr. Harshal Shah

Designation :

Accounts Department

Contact No.:

91-8511174070

 

 

LOCATIONS

 

Registered Office :

882/1 – 871, VL. Rajoda, Near Hotel Kankavati, Bavla – 382 220, Gujarat, India

Tel. No.:

91-2714-304700

Mobile No.:

91-8511174070 (Mr. Harshal Shah)

Fax No.:

Not Available

E-Mail :

sandipv@amneal.com

accounts@amnealindia.com

Website :

http://www.amnealindia.com

Location :

Owned

 

 

Research and Development / Manufacturing Facility :

Plot No. 15, 16, 17, “PHARMEZ” Special Economic Zone, Sarkhej – Bawla Highway, Matoda, Taluka Sanand, District Ahmedabad – 382210, Gujarat, India

 

 

Factory:

Located At :

·         New York

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mr. Suresh Punambhai Patel

Designation :

Director

Address :

Block No. 54, Shri Somnathnagar C, Housing Society lImited, Behind Sanghvi School, Narangpura Road, Wadaj, Ahmedabad – 380 013, Gujarat, India

Date of Birth/Age :

15.03.1961

Date of Appointment :

31.03.2008

DIN No.:

01856345

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231GJ2006PTC048109

AMNEAL PHARMACEUTICALS COMPANY (INDIA) PRIVATE LIMITED

Whole-time director

01/10/2011

07/04/2006

Active

NO

2

U73100GJ2008PTC053430

AMNEAL LIFE SCIENCES PRIVATE LIMITED

Director

31/03/2008

31/03/2008

Active

NO

3

U24233GJ2008PTC068526

RAKS PHARMA PRIVATE LIMITED

Director

30/09/2011

30/07/2010

Active

NO

 

 

Name :

Mr. Kanubhai Punambhai Patel

Designation :

Director

Address :

22 Ramyakunj Society Opposite Galaxy Cinema, N H NO 8 Naroda -  382325, Ahmedabad, Gujarat, India

Date of Birth/Age :

31.08.1942

Date of Appointment :

31.03.2008

DIN No.:

01883090

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231GJ2006PTC048109

AMNEAL PHARMACEUTICALS COMPANY (INDIA) PRIVATE LIMITED

Director

17/11/2007

17/11/2007

Active

NO

2

U73100GJ2008PTC053430

AMNEAL LIFE SCIENCES PRIVATE LIMITED

Director

31/03/2008

31/03/2008

Active

NO

 

 

Name :

Ms. Chintu Patel

Designation :

Director

Address :

115 Northfield Road, Parsippany, New Jersey -  070543167

Date of Birth/Age :

05.10.1971

Date of Appointment :

31.03.2008

DIN No.:

01980171

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231GJ2006PTC048109

AMNEAL PHARMACEUTICALS COMPANY (INDIA) PRIVATE LIMITED

Director

07/04/2006

07/04/2006

Active

NO

2

U73100GJ2008PTC053430

AMNEAL LIFE SCIENCES PRIVATE LIMITED

Director

31/03/2008

31/03/2008

Active

NO

 

 

Name :

Mr. Nikunj Bansibhai Patel

Designation :

Director

Address :

A/29/A, Karmachari Nagar, Society, Part-1, Opposite M Kapuri Society, Ghatlodia, Ahmedabad – 380 061, Gujarat, India

Date of Appointment :

30.09.2013

DIN No.:

02790495

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231GJ2006PTC048109

AMNEAL PHARMACEUTICALS COMPANY (INDIA) PRIVATE LIMITED

Whole-time director

01/10/2011

01/09/2009

Active

NO

2

U24233GJ2008PTC068526

RAKS PHARMA PRIVATE LIMITED

Director

30/09/2011

30/07/2010

Active

NO

3

U73100GJ2008PTC053430

AMNEAL LIFE SCIENCES PRIVATE LIMITED

Director

30/09/2013

23/09/2013

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Pushpa Joshi

Designation :

Secretary

Address :

A-505, Smaruna Apartments, Near  Torrent Power, Bakers City, Vejalpur, Ahmedabad – 380 051, Gujarat, India

Date of Appointment :

04.09.2012

PAN No.:

AXSPP6822A

 

 

MAJOR SHAREHOLDERS

 

AS ON 30.09.2013

 

Names of Shareholders

 

 

No. of Shares

 

Amneal Pharmaceuticals LLC, Paterson, NJ

 

12564514

Amneal Pharma Investment Holding Mauritius, Mauritius

 

30642531

Suresh Patel

 

100

Kanubhai Punambhai Patel

 

1260000

Nikunj Patel

 

2073000

 

 

 

Total

 

46540145

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 30.09.2013

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

92.80

Directors or relatives of Directors

7.20

 

 

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Pharmaceutical Bulk Drugs.

 

GENERAL INFORMATION

 

No. of Employees :

600 (Approximately)

 

 

Bankers :

Bank of Baroda, Shapath – III, Ground Floor, Near GNFC Info Tower, Badakdev, Ahmedabad – 380 054, Gujarat, India

 

 

Facilities :

SECURED LOANS

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

 

 

Term Loans from Banks

859.090

621.594

 

 

 

Total

859.090

621.594

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S.V. Ghatalia and Associates LLP

Chartered Accountants

Address :

2nd Floor, Shivalik Ishaan, Near C N Vidhyalaya, Ambawadi, Ahmedabad – 380 015, Gujarat, India

PAN No.:

ACHFS9181P

 

 

Associates :

·         Amneal Pharmaceuticals Company (India) Private Limited, India  [U24231GJ2006PTC048109]

·         Amneal Pharma Investment Holdings, United States

 

 

Subsidiaries :

·         Raks Pharma Private Limited

·         Kanan LLC

 

CAPITAL STRUCTURE

 

AS ON 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

60000000

Equity Shares

Rs.10/- each

Rs.600.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

46540145

Equity Shares

Rs.10/- each

Rs.465.401 Millions

 

 

 

 

 

 

AS ON 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000000

Equity Shares

Rs.10/- each

Rs.500.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

27124616

Equity Shares

Rs.10/- each

Rs.271.246 Millions

 

 

 

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

        I.            EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

271.246

217.068

125.646

(b) Reserves & Surplus

(6.289)

0.000

0.000

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

264.957

217.068

125.646

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

859.090

621.594

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.242

0.000

0.000

Total Non-current Liabilities (3)

859.332

621.594

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

0.000

0.000

0.000

(c) Other current liabilities

81.017

10.811

0.231

(d) Short-term provisions

4.500

0.416

0.019

Total Current Liabilities (4)

85.517

11.227

0.250

 

 

 

 

TOTAL

1209.806

849.889

125.896

 

 

 

 

      II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

95.894

92.891

92.235

(ii) Intangible Assets

0.000

0.028

0.000

(iii) Capital work-in-progress

811.685

130.888

9.518

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

160.587

2.346

0.520

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

1068.166

226.153

102.273

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

350.043

0.000

(b) Inventories

0.000

0.000

0.000

(c) Trade receivables

0.000

0.000

0.000

(d) Cash and cash equivalents

131.407

242.189

23.457

(e) Short-term loans and advances

9.566

30.947

0.166

(f) Other current assets

0.667

0.557

0.000

Total Current Assets

141.640

623.736

23.623

 

 

 

 

TOTAL

1209.806

849.889

125.896

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Debt Equity Ratio

(Total Debt /Networth)

 

3.24

2.86

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.66

55.56

94.49

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

No

12]

Profitability for last three years

No

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10333830

04/01/2014 *

2,024,500,000.00

BANK OF BARODA

SHAPATH-III, GROUND FLOOR, NEAR. GNFC INFO TOWER, BODAKDEV, AHMEDABAD - 380054, GUJARAT, INDIA

B93501203

 

* Date of charge modification

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.45

UK Pound

1

Rs.102.01

Euro

1

Rs.84.35

 

 

INFORMATION DETAILS

 

Report Prepared by :

NKT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.